Molecular Partners AG

MOLN

$4.35

+6.88%

N/A+$0.28

Healthcare

Biotechnology

NASDAQ

Active Trading

Molecular Partners AG operates as a clinical-stage biopharmaceutical company, specializing in the identification, advancement, and commercialization of innovative therapeutic proteins. The firm's ...

Supply Chain of MOLN

Upstream / Downstream / Proxies

Upstream

AGC Biologics (a Division of AGC Inc.)TSE:5201Eckert & Ziegler SEXTRA:EUZGOrano Med (Subsidiary of Orano Group)Various Clinical CROs (unidentified from public sources)AGC Inc. (Parent Company of AGC Biologics)TSE:5201Orano Group (Parent of Orano Med)

Downstream

Orano Med (Subsidiary of Orano Group)Novartis AGSIX:NOVNAmgen Inc.NASDAQ:AMGN AbbVie Inc. (via Allergan subsidiary)NYSE:ABBV

Proxies

Affimed N.V.NASDAQ:AFMD MacroGenics Inc.NASDAQ:MGNX Xencor Inc.NASDAQ:XNCR CytomX Therapeutics Inc.NASDAQ:CTMX

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer